FMP
ShockWave Medical, Inc.
SWAV
NASDAQ
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
329 USD
1.48 (0.45%)
About
ceo
Mr. Douglas E. Godshall M.B.A.
sector
Healthcare
industry
Medical - Devices
website
https://www.shockwavemedical.com
exchange
NASDAQ
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
CIK
0001642545
ISIN
US82489T1043
CUSIP
82489T104
Address
5403 Betsy Ross Drive
Phone
510 279 4262
Country
US
Employee
1,468
IPO Date
Mar 7, 2019
Key Executives
